Related Experiment Video
Updated: May 8, 2026
06:21
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
11.1K
[Sex differences in pancreatic cancer]
Magdalena Holze1,2, Azaz Ahmed3,4, Martin Loos1
1Klinik für Allgemein‑, Viszeral- und Transplantationschirurgie, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.
Chirurgie (Heidelberg, Germany)
|August 15, 2024
Summary
Biological and social sex impact pancreatic cancer treatment and outcomes. Women experience different treatment patterns and survival rates, with a lower quality of life despite longer survival.
Area of Science:
- Oncology
- Immunology
- Surgical Outcomes
Background:
- Pancreatic cancer exhibits significant gender disparities in incidence, treatment response, and prognosis.
- Biological and social sex influence immune responses, impacting cancer treatment efficacy and patient survival.
Purpose of the Study:
- To review the evidence on the role of biological and social sex in pancreatic cancer.
- To analyze sex-based differences in operative, perioperative, and multimodal treatment contexts.
Main Methods:
- Comprehensive literature review of existing evidence on sex differences in pancreatic cancer.
- Analysis of data concerning treatment modalities, immune responses, and patient outcomes.
Main Results:
- Women with pancreatic cancer show distinct patterns, including less systemic treatment and delayed surgery, but better perioperative outcomes.
- Female patients generally experience longer survival under treatment but report lower quality of life and higher disease burden.
Conclusions:
- Sex is a critical factor influencing pancreatic cancer's incidence, treatment response, and prognosis.
- Understanding these sex differences is vital for optimizing treatment strategies and improving patient care in pancreatic cancer.
